In the dynamic and fragmented Biotechnology industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.

Our collection of strategic assessments of leading Biotechnology companies provides significant competitor information, analysis and insight critical to the development and implementation of effective business, marketing and R&D programs. The assessments include latest organizational and management developments, acquisitions and divestitures, marketing tactics, financial results, strengths and weaknesses, and strategic directions.

Alexion
Alnylam
Biomarin
Exelixis
Incyte
Intercept Pharma
Ionis Pharma
Jazz Pharma
Novo Nordisk
Regeneron
Seattle Genetics
United Therapeutics
Vertex Pharma

These reports will complement your internal competitor information gathering efforts with objective strategic analysis, data interpretation and insight.

The reports will also assist current competitors and potential market entrants in evaluating prospective acquisitions and joint venture candidates.